Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial

posted on Sep 02, 2018 12:42PM

Weill Cornell Medicine - New York Presbyterian (New York, New York, USA)

Seattle Cancer Care Alliance ( Seattle, Washington, USA)

That brings it up to six active USA study sites.

ClinicalTrials.gov listing updated last week:

https://clinicaltrials.gov/ct2/show/NCT02711956

5 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply